Clinical Trials
3
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)โข Click on a phase to view related trials
Implementing Fragmentomics Into Real World Screening IntervenTions to Evaluate Clinical Utility Among Individuals With Elevated Risk for Lung Cancer
- Conditions
- Lung Cancer
- First Posted Date
- 2023-11-24
- Last Posted Date
- 2025-07-03
- Lead Sponsor
- Delfi Diagnostics Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT06145750
- Locations
- ๐บ๐ธ
DARTNet Institute, Aurora, Colorado, United States
๐บ๐ธUniversity Of Florida, Jacksonville, Florida, United States
๐บ๐ธDuke University, Durham, North Carolina, United States
CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung
- Conditions
- Lung Cancer
- First Posted Date
- 2022-04-01
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- Delfi Diagnostics Inc.
- Target Recruit Count
- 11935
- Registration Number
- NCT05306288
- Locations
- ๐บ๐ธ
Cullman Clinical Trials, Cullman, Alabama, United States
๐บ๐ธScience 37 (nationwide digital enrollment), Culver City, California, United States
๐บ๐ธProvidence Facey Medical Foundation, Mission Hills, California, United States
DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)
- Conditions
- Lung CancerBladder CancerKidney CancerColorectal CancerLiver CancerHead and Neck CancerEsophageal CancerPancreas CancerSkin CancerStomach Cancer
- First Posted Date
- 2021-04-01
- Last Posted Date
- 2025-07-03
- Lead Sponsor
- Delfi Diagnostics Inc.
- Target Recruit Count
- 2660
- Registration Number
- NCT04825834
- Locations
- ๐บ๐ธ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
๐บ๐ธThe Cleveland Clinic Foundation, Cleveland, Ohio, United States